The identification of individuals with latent autoimmune diabetes of adults (LADA) is relevant for therapeutic decisions [7], since these individuals need insulin therapy much earlier than those with classical type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.